Clinical research in the Women and Children’s Blood Disorders Program focuses on the short- and long-term burden of preeclampsia for mother and baby. Our researchers place a special emphasis on evaluating potential treatment options for the condition and related disorders. We have established a robust database of genomic, proteomic and other biomarkers to help predict, diagnose, and monitor the progression of preeclampsia. This research is an important step in helping to identify and better understand the cause of preeclampsia, which is currently unknown.
Visit yalestudies.org to view available clinical trials or learn more about clinical research at Yale.